https://www.selleckchem.com/pr....oducts/Streptozotoci
MDDN is a novel diagnostic tool for corneal diseases that can be used to automatically diagnose KCN, FED, and DES using only AS-OCT images. To assess the activity of reproxalap, a novel reactive aldehyde species (RASP) inhibitor, relative to vehicle in patients with dry eye disease (DED) DESIGN Randomized, double-masked, vehicle-controlled Phase 2b trial METHODS Three hundred patients with DED were randomly assigned 111 at multiple US sites to receive 0.1% topical ocular reproxalap, 0.25% topical ocular reproxalap, or vehicle. Ey
Like
Comment
Share
